Lexaria Bioscience Corp. (LEXX)

NASDAQ

$2.80

$+0.05

(+2.01%)

Regular Market

Lexaria Bioscience Corp. (LEXX) Live Price Chart

Last updated: ⁦2026-10-22 19:20:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Lexaria Bioscience Corp. (LEXX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.80, with a market capitalization of $5.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.43 to $21.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.58M
Open	$2.74
Day's High	$187.50
Day's Low	$2.43
Previous Close	$2.82
Volume	10.11K
Average Volume	74.90K
P/E Ratio	--
52-Week High	$21.60
52-Week Low	$2.43
Dividend Yield	--
Earnings Date	--

Lexaria Bioscience Corp. (LEXX) Stock Price Today

Lexaria Bioscience Corp. (LEXX) is currently trading at $2.80 as of 2026-10-22 19:10:00, down 0.89% ($0.02) from the previous close of $2.82

During today's regular trading session, LEXX has traded between $2.43 and $187.50, with a trading volume of 10.11K shares. The current price is near the lower end of today's range.

Lexaria Bioscience Corp. (LEXX) 7-Day Stock Price Change

Over the past seven days, Lexaria Bioscience Corp. (LEXX) moved from $2.80 to $2.80, representing a decline of 0.18% ($0.00).

The stock traded between $2.43 and $3.29 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 72.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

LEXX 52-Week Price Position

Position in Range: 1.9%

52W Low$2.43

52W High$21.60

LEXX is currently trading at $2.80, placing it 1.9% of the way from its 52-week low of $2.43 to its 52-week high of $21.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lexaria Bioscience Corp. (LEXX)?

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Lexaria Bioscience Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	7
Exchange	NASDAQ
Company Website	https://www.lexariabioscience.com

How to Buy Lexaria Bioscience Corp. (LEXX) Stock on MEXC

Eligible investors can buy real shares of Lexaria Bioscience Corp. (LEXX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LEXX and Place Your Order

Open the RealStocks trading page and search for LEXX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lexaria Bioscience Corp. (LEXX) stock price today?

Lexaria Bioscience Corp. (LEXX) is currently trading at $ 2.80, down 0.89% ($0.02) from the previous close of $ 2.82. Intraday prices update in real time during regular trading hours.

2.Is LEXX stock going up or down today?

As of 2026-10-22 19:10:00, LEXX is trading at $ 2.80, down 0.89% ($0.02) from its previous close of $ 2.82. The stock has traded between $ 2.43 and $ 187.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is LEXX pre-market price?

As of 2026-10-22 19:10:00, LEXX is trading at $ 2.65 in pre-market trading, down 6.06% ($0.17) from the previous close of $ 2.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LEXX after-hours price?

As of 2026-10-22 19:10:00, LEXX is trading at $ 2.73 in after-hours trading, down 3.09% ($0.09) from the regular-session close of $ 2.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LEXX stock trading now?

LEXX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LEXX sit relative to its 52-week high and low?

Over the past 52 weeks, LEXX has traded between a low of $ 2.43 and a high of $ 21.60. At $ 2.80, the stock is positioned 1.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lexaria Bioscience Corp. in?

Lexaria Bioscience Corp. (LEXX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lexaria Bioscience Corp.'s market capitalization and where is it listed?

Lexaria Bioscience Corp. is listed on the NASDAQ exchange with a market capitalization of $ 5.58M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LEXX valued in terms of P/E ratio and EPS?

LEXX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.67. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lexaria Bioscience Corp. pay a dividend?

Lexaria Bioscience Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.